Tangye, S G <br/><br/>
Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.  [electronic resource] 

 -  Leukemia & lymphoma  Sep 1998 
 - 121-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199809057592  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD5 Antigens--blood<br/>Cell Division--drug effects<br/>Cell Survival--drug effects<br/>Cytokines--pharmacology<br/>Humans<br/>Immunoglobulins--immunology<br/>Interleukin-10--therapeutic use<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Lymphocyte Activation<br/>RNA, Neoplasm--biosynthesis<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Tumor Cells, Cultured